Kevin Gelston is a Business Operations & Strategy Associate at Ipsen, leveraging his recent MIT Sloan MBA to bridge science and business. With a background as a formulation scientist, he has led drug development programs from concept to clinical trials. Colleagues describe him as an analytical and diligent researcher.
Fueled by a passion for biotech innovation, Kevin is dedicated to translating scientific advancements into transformative therapies. His focus is on creating a lasting, positive impact for patients by bringing new treatments to market. He is deeply invested in the real-world application of cutting-edge biotechnology.
Unique fact: He led the development of a topical drug for atopic dermatitis that achieved a 95% treatment success rate in its Phase 2A clinical trial.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.